Lannett Co Inc – Consensus Says Potential Hike of 41.0%
Lannett Cie Inc found using the ticker (LCI) now have 4 analysts covering the headline with the consensus suggesting a rating of “Hold”. The range between the high target price and the low target price is between 7.5 and 5 by calculating the average target price that we see 5.88. With the stock’s previous close at 4.17, that would imply a potential rise of 41.0%. There is a 50-day moving average of 4.66 and the 200-day moving average is 6. The company has a market cap of $ 180 million. You can visit the company’s website by visiting: http://www.lannett.com
Lannett Company develops, manufactures, packages, markets and distributes generic versions of brand name pharmaceuticals in the United States. The company offers finished dosage forms of solid oral and sustained release, topical, liquid, nasal and oral drugs that address a wide range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual solutions. , suspensions, soft gel, injectable and oral doses. It also supplies its products for various medical indications, such as analgesic, antipsychotic, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious diseases, migraine, respiratory / allergy / cough / cold, urinary and other medical indications. The company’s main products include Levothyroxine Sodium Tablets, Fluphenazine Tablets, Posaconazole DR Tablets, Verapamil SR Tablets, Methylphenidate CD Capsules, Omeprazole Capsules, Pantoprazole Sodium DR Tablets, nasal spray Sumatriptan, metolazone tablets, IR amphetamine tablets, methylphenidate hydrochloride as well as ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic drug distributors, drug wholesalers, drug retail chains, private label distributors, mail order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, government entities and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, the HEC group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm and various other companies. Lannett Company was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.